Global Cord Blood Corporation (CO) Tops Q3 EPS by 4c

Global Cord Blood Corporation (NYSE: CO) reported Q3 EPS of $0.17, $0.04 better than the analyst estimate of $0.13. Revenue for the quarter came in at $48.1 million versus the consensus estimate of $39.36 million.

For earnings history and earnings-related data on Global Cord Blood Corporation (CO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c